用诱导的多能干细胞建模长QT综合征
Ilanit Itzhaki1, Leonid Maizels, Irit Huber
1Sohnis Family Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, POB 9649, Haifa 31096, Israel.
Nature
|January 18, 2011
概括
患者特异的人类诱导多能干细胞 (iPSCs) 成功模拟长QT综合征 (LQTS),揭示了心脏电流减少和心律失常. 这个iPSC模型有助于测试遗传性心脏疾病和个性化医学的药物.
科学领域:
- 心血管研究研究心血管研究
- 干细胞生物学 干细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 先天性长QT综合征 (LQTS) 是一种遗传性疾病,导致心律异常和心脏突然死亡.
- 患者特异的人类诱导多能干细胞 (iPSCs) 为疾病建模和药物发现提供了强大的工具.
研究的目的:
- 从患有2型LQTS的患者中开发和表征一种患者特异的人类iPSC线.
- 通过使用iPSC衍生的心肌细胞在体外建模LQTS表型.
- 用这个模型来评估潜在的治疗药物.
主要方法:
- 来自KCNH2基因突变的LQTS患者的iPSCs的生成.
- 将iPSCs分化为心肌细胞.
- 电生理学记录 (补丁,多电极阵列) 来评估心脏功能.
- 在iPSC衍生的心脏组织上对各种药物类别的药理学测试.
主要成果:
- 来自LQTS患者的iPSC衍生的心肌细胞表现出延长的动作潜力持续时间和减少的I(Kr) 电流.
- 来自LQTS的细胞表现出心律失常性,包括早期的脱极化和触发心律失常.
- 该iPSC模型成功预测了通道阻断剂的影响,并确定了潜在的改善剂.
结论:
- 人类iPSC技术可以准确地模拟LQTS等遗传性心脏疾病的功能表型.
- 这种患者特异性的iPSC衍生的心脏模型对于研究疾病机制和确定新的治疗策略是有价值的.
- iPSC技术代表了个性化医疗和心血管疾病药物开发的有希望的方法.
更多相关视频
相关概念视频
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.